Landos Biopharma Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Landos Biopharma Inc's ROI in the first quarter of 2024?
Landos Biopharma Inc recorded a cumulative net loss of $-25 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -73%.

Within the Healthcare sector 17 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 83 to 88.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Investment Change TTM	-25.22 %	-18.82 %	-28.57 %	-38.91 %	-46.27 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	23	32	38	43	47
Return On Investment (TTM)	-73 %	-54.92 %	-50.39 %	-53.24 %	-67.03 %
LABP's Overall Ranking	# 88	# 83	# 4486	# 4171	#
Seq. Investment Change TTM	-14.94 %	-4.39 %	-3.66 %	-4.54 %	-7.66 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-25	-22	-21	-23	-30

LABP Company Profile >> Back to LABP Roi Comparisons >> See Annual LABP Return On Investment

Return On Investment LABP's Ranking
Within:	No.
Industry	# 6
Sector	# 18
Overall	# 88

Return On Investment Statistics
High	Average	Low
48.49 %	-19.3 %	-51.42 %
(Dec 31 2023)		(Mar 31 2022)

Financial Statements
Landos Biopharma Inc's I. Quarter Investments	$ 23 Millions	LABP's Balance sheet
Landos Biopharma Inc's I. Quarter Income	$ -9 Millions	Quarterly LABP's Income Statement
LABP's Income by Division		See LABP's Income by Division

LABP Annual Return On Investment	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	32	39	76	0	0
Y / Y Investment Growth	-18.76 %	-48.69 %	-	-	-
Net Income in Millions	-22	-39	-38	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-69 %	-100.37 %	-50.38 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LABP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LABP's Competitors
Subscribers only: Roi for Landos Biopharma Inc's Suppliers
Subscribers only: Return On Investment for LABP's Customers

Other Ratios
LABP's Roa	LABP's Inventory Turnover Ratio	LABP's Growth Rates	LABP's Dividend Statistics
	LABP's Profitability Ratios	LABP's Asset Turnover Ratio	LABP's Dividend Growth
LABP's Roe	LABP's Valuation Ratios	LABP's Financial Strength Ratios	LABP's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:22:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.